NCT00931528 · OUTCOME
Patient Marital Adjustment as Measured by the Locke's Marital Adjustment Test
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEAN
- Unit
- change in LMAT score
- Interval / dispersion
- Standard Deviation
- Time frame
- Baseline, week 30 and years 1 and 2 after the start of treatment
What was measured
The Locke Marital Adjustment Test (LMAT) is a 16-item questionnaire with scores ranging from 48 to 138 for participants. Higher scores indicate greater sexual function, sexual wellbeing, or marital adjustment. The change in LMAT score is calculated by subtracting the baseline score from the follow-up score.
Analysis population: Eligible patients with data at baseline and time point of interest.
Groups in this outcome
Tadalafil
Beginning ≤ 7 days after the start of radiotherapy, patients receive oral tadalafil 5mg once daily for 24 weeks.
Placebo
Beginning ≤ 7 days after the start of radiotherapy, patients receive oral placebo once daily for 24 weeks.
| Group | Source count |
|---|---|
| Tadalafil | 61 |
| Placebo | 60 |
Reported measurements
Week 30
| Group | Source count |
|---|---|
| Tadalafil | 35 |
| Placebo | 29 |
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Tadalafil | -3.5 | 7.7 | Not reported | Not reported | Not reported |
| Placebo | -2.6 | 10.4 | Not reported | Not reported | Not reported |
Year 1
| Group | Source count |
|---|---|
| Tadalafil | 22 |
| Placebo | 23 |
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Tadalafil | -1.9 | 7.2 | Not reported | Not reported | Not reported |
| Placebo | -1.9 | 6.3 | Not reported | Not reported | Not reported |
Year 2
| Group | Source count |
|---|---|
| Tadalafil | 27 |
| Placebo | 27 |
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Tadalafil | -1.3 | 9.87 | Not reported | Not reported | Not reported |
| Placebo | -1.4 | 5.4 | Not reported | Not reported | Not reported |
Source statistical analyses
- group Description
- Week 30
- group Ids
- OG000
- OG001
- non Inferiority Type
- SUPERIORITY
- p Value
- 0.67
- statistical Comment
- Significance level = 0.05
- statistical Method
- t-test, 2 sided
- group Description
- Year 1
- group Ids
- OG000
- OG001
- non Inferiority Type
- SUPERIORITY
- p Value
- 0.98
- statistical Comment
- Significance level = 0.05
- statistical Method
- t-test, 2 sided
- group Description
- Year 2
- group Ids
- OG000
- OG001
- non Inferiority Type
- SUPERIORITY
- p Value
- 0.96
- statistical Comment
- Significance level = 0.05
- statistical Method
- t-test, 2 sided
Complete source fields
- analyses
- group Description
- Week 30
- group Ids
- OG000
- OG001
- non Inferiority Type
- SUPERIORITY
- p Value
- 0.67
- statistical Comment
- Significance level = 0.05
- statistical Method
- t-test, 2 sided
- group Description
- Year 1
- group Ids
- OG000
- OG001
- non Inferiority Type
- SUPERIORITY
- p Value
- 0.98
- statistical Comment
- Significance level = 0.05
- statistical Method
- t-test, 2 sided
- group Description
- Year 2
- group Ids
- OG000
- OG001
- non Inferiority Type
- SUPERIORITY
- p Value
- 0.96
- statistical Comment
- Significance level = 0.05
- statistical Method
- t-test, 2 sided
- classes
- categories
- measurements
- group Id
- OG000
- spread
- 7.7
- value
- -3.5
- group Id
- OG001
- spread
- 10.4
- value
- -2.6
- denoms
- counts
- group Id
- OG000
- value
- 35
- group Id
- OG001
- value
- 29
- units
- Participants
- title
- Week 30
- categories
- measurements
- group Id
- OG000
- spread
- 7.2
- value
- -1.9
- group Id
- OG001
- spread
- 6.3
- value
- -1.9
- denoms
- counts
- group Id
- OG000
- value
- 22
- group Id
- OG001
- value
- 23
- units
- Participants
- title
- Year 1
- categories
- measurements
- group Id
- OG000
- spread
- 9.87
- value
- -1.3
- group Id
- OG001
- spread
- 5.4
- value
- -1.4
- denoms
- counts
- group Id
- OG000
- value
- 27
- group Id
- OG001
- value
- 27
- units
- Participants
- title
- Year 2
- denoms
- counts
- group Id
- OG000
- value
- 61
- group Id
- OG001
- value
- 60
- units
- Participants
- description
- The Locke Marital Adjustment Test (LMAT) is a 16-item questionnaire with scores ranging from 48 to 138 for participants. Higher scores indicate greater sexual function, sexual wellbeing, or marital adjustment. The change in LMAT score is calculated by subtracting the baseline score from the follow-up score.
- dispersion Type
- Standard Deviation
- groups
- description
- Beginning ≤ 7 days after the start of radiotherapy, patients receive oral tadalafil 5mg once daily for 24 weeks.
- id
- OG000
- title
- Tadalafil
- description
- Beginning ≤ 7 days after the start of radiotherapy, patients receive oral placebo once daily for 24 weeks.
- id
- OG001
- title
- Placebo
- param Type
- MEAN
- population Description
- Eligible patients with data at baseline and time point of interest.
- reporting Status
- POSTED
- time Frame
- Baseline, week 30 and years 1 and 2 after the start of treatment
- title
- Patient Marital Adjustment as Measured by the Locke's Marital Adjustment Test
- type
- SECONDARY
- unit Of Measure
- change in LMAT score
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle